申请人:Hunt Julianne A.
公开号:US20100197630A1
公开(公告)日:2010-08-05
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are potent CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In formula I, A-B is an arylamide moiety.
具有I式结构的化合物,包括该化合物的药物可接受的盐,是有效的CETP抑制剂,可用于提高高密度脂蛋白胆固醇,降低低密度脂蛋白胆固醇,并用于治疗或预防动脉硬化。在公式I中,A-B是一个芳香酰胺基团。